Marek Malecki
- Co-authors
- Hans RisWaclaw SzybalskiMark E. AndersonChelsea SaboI. DeradoN. SchmitzK. KadijaP. Seyboth
- Topics
- CRISPR and Genetic Engineering (7 papers)Virus-based gene therapy research (6 papers)Pluripotent Stem Cells Research (6 papers)
- Partner nations
- United StatesUnited KingdomPoland
In The Last Decade
Marek Malecki
38 papers receiving 300 citations
Peers
Comparison fields: 5 of 60
- Molecular Biology 235
- Genetics 67
- Oncology 45
- Surgery 34
- Radiology, Nuclear Medicine and Imaging 23
Countries citing papers authored by Marek Malecki
This map shows the geographic impact of Marek Malecki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marek Malecki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marek Malecki more than expected).
Fields of papers citing papers by Marek Malecki
This network shows the impact of papers produced by Marek Malecki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marek Malecki. The network helps show where Marek Malecki may publish in the future.
Co-authorship network of co-authors of Marek Malecki
This figure shows the co-authorship network connecting the top 25 collaborators of Marek Malecki. A scholar is included among the top collaborators of Marek Malecki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marek Malecki. Marek Malecki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 5 | |
| 2 | 16 | |
| 3 | Cancer suicide gene therapy: Apoptosis of the ovarian cancer cells induced by EGFRvIII targeted delivery and cell nucleus targeted expression of the DNA-ase transgenes | 4 |
| 4 | 13 | |
| 5 | 10 | |
| 6 | 7 | |
| 7 | 19 | |
| 8 | 2 | |
| 9 | 4 | |
| 10 | 18 | |
| 11 | Macierzyste komórki nowotworowe, a oporność nowotworów na terapię | 1 |
| 12 | OVARIAN CANCER SUICIDE GENE THERAPY WITH GENETICALLY ENGINEERED, TRANSGENICALLY EXPRESSED, INTRACELLULAR scFv ANTIBODIES AGAINST ANTI-OXIDATIVE ENZYMES. | 8 |
| 13 | HER2/NEU GENE EXPRESSION PRODUCTS EVALUATED WITH SUPERPARAMAGNETIC, GENETICALLY ENGINEERED ANTIBODIES. | 4 |
| 14 | 1 | |
| 15 | 39 | |
| 16 | 2 | |
| 17 | Preparation of plasmid DNA in transfection complexes for fluorescence and electron spectroscopic imaging. | 6 |
| 18 | 5 | |
| 19 | High voltage electron microscopy and low voltage scanning electron microscopy of human neoplastic cell culture. | 3 |
| 20 | 6 |
About Marek Malecki
Marek Malecki is a scholar working on Structural Biology, Virology and Surfaces, Coatings and Films, having authored 42 papers that have together received 347 indexed citations. Recurring topics across this work include CRISPR and Genetic Engineering (7 papers), Virus-based gene therapy research (6 papers) and Pluripotent Stem Cells Research (6 papers). The work is most often cited by research in Structural Biology (16 citations), Molecular Biology (235 citations) and Virology (14 citations). Marek Malecki has collaborated with scholars based in United States, United Kingdom and Poland. Frequent co-authors include Hans Ris, Waclaw Szybalski, Mark E. Anderson, Chelsea Sabo, I. Derado, N. Schmitz, K. Kadija, P. Seyboth, J. Victor Small and Paul Zarogoulidis. Their work appears in journals such as Proceedings of the National Academy of Sciences, Trends in Cell Biology and Gene.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.